Editing Cystic fibrosis (section)

==== ''Pseudomonas aeruginosa'' ====
The early management of ''Pseudomonas aeruginosa'' infection is usually suggested using nebulised antibiotics with or without oral antibiotics to remove the bacteria from the person's airways for some time.<ref name="pmid37268599">{{cite journal | vauthors = Langton Hewer SC, Smith S, Rowbotham NJ, Yule A, Smyth AR | title = Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis | journal = The Cochrane Database of Systematic Reviews | volume = 2023 | issue = 6 | pages = CD004197 | date = June 2023 | pmid = 37268599 | pmc = 10237531 | doi = 10.1002/14651858.CD004197.pub6 }}</ref> When choosing antibiotics to treat lung infections caused by ''Pseudomonas aeruginosa'' in people with cystic fibrosis, it is still unclear whether the choice of antibiotics should be based on the results of testing antibiotics separately (one at a time) or in combination with each other.<ref name="pmid32412092">{{cite journal | vauthors = Smith S, Ratjen F, Remmington T, Waters V | title = Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis | journal = The Cochrane Database of Systematic Reviews | volume = 5 | issue = 5 | pages = CD006961 | date = May 2020 | pmid = 32412092 | pmc = 7387858 | doi = 10.1002/14651858.CD006961.pub5 }}</ref> It is also unclear if these treatment approaches for the ''Pseudomonas aeruginosa'' infection improve the person's quality of life or lifespan.<ref name="pmid37268599" /> The negative side effects of antibiotics for this infection are also poorly studied.<ref name="pmid37268599" /> Intravenous antibiotic therapy to treat ''Pseudomonas aeruginosa'' infections is not any better than antibiotics taken orally.<ref name="pmid37268599" />